| 國立臺灣海洋大學 |
2001 |
Recombinant Expression and Characterization of the Candida rugosa lip4 Lipase in Pichia pastoris: Comparison of Glycosylation, Activity and Stability
|
Shye-Jye Tang; Jei-Fu Shaw; Kuang-Hui Sun; Guang-Huan Sun; Terng-Yuan Chang; Ching-Kai Lin; Yuh-Chih Lo |
| 國立臺灣大學 |
2010 |
Recombinant expression of bioactive peptide lunasin in Escherichia coli
|
Liu, Chin-Feng; Pan, Tzu-Ming |
| 國立成功大學 |
2012-12 |
Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers
|
Anangi, R (Anangi, Raveendra); Koshy, S (Koshy, Shyny); Huq, R (Huq, Redwan); Beeton, C (Beeton, Christine); Chuang, WJ (Chuang, Woei-Jer); King, GF (King, Glenn F.) |
| 臺大學術典藏 |
2018-09-10T09:14:23Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Wang, A.-Y. and Yuan, A. and Huang, C.-H. and Chang, W.-T. and Liang, P.-C. and Lin, T.-H. and Chen, S.-C.; PO-CHIN LIANG; CHIEN-HUA HUANG; SHYR-CHYR CHEN; ANG YUAN; WEI-TIEN CHANG; TZU-HSIN LIN; PO-CHIN LIANG; CHIEN-HUA HUANG; SHYR-CHYR CHEN; ANG YUAN; WEI-TIEN CHANG; TZU-HSIN LIN |
| 臺大學術典藏 |
2020-03-12T02:02:42Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Chen S.-C.; Lin T.-H.; Liang P.-C.; WEI-TIEN CHANG; Huang C.-H.; Yuan A.; Chen S.-C.;Lin T.-H.;Liang P.-C.;WEI-TIEN CHANG;Huang C.-H.;Yuan A.;Wang A.-Y.; Wang A.-Y. |
| 臺大學術典藏 |
2012 |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Chen S.-C.;Lin T.-H.;Liang P.-C.;Chang W.-T.;CHIEN-HUA HUANG;Yuan A.;Wang A.-Y.; Wang A.-Y.; Yuan A.; CHIEN-HUA HUANG; Chang W.-T.; Liang P.-C.; Lin T.-H.; Chen S.-C. |
| 臺大學術典藏 |
2020-03-25T03:28:02Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Chen S.-C.; Lin T.-H.; Liang P.-C.; Chen S.-C.;Lin T.-H.;Liang P.-C.;WEI-TIEN CHANG;Huang C.-H.;Yuan A.;Wang A.-Y.; Wang A.-Y.; Yuan A.; Huang C.-H.; WEI-TIEN CHANG |
| 臺大學術典藏 |
2020-03-26T06:54:22Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Chen S.-C.; Lin T.-H.; Liang P.-C.; Chang W.-T.; Huang C.-H.; ANG YUAN; Wang A.-Y. |
| 臺大學術典藏 |
2020-08-11T08:36:52Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Lin T.-H.; Chen S.-C.; PO-CHIN LIANG; Chang W.-T.; Huang C.-H.; Yuan A.; Wang A.-Y.; Wang A.-Y.;Yuan A.;Huang C.-H.;Chang W.-T.;Po-Chin Liang;Lin T.-H.;Chen S.-C. |
| 臺大學術典藏 |
2020-03-25T02:36:51Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
SHYR-CHYR CHEN; Lin T.-H.; Liang P.-C.; Chang W.-T.; SHYR-CHYR CHEN;Lin T.-H.;Liang P.-C.;Chang W.-T.;Huang C.-H.;Yuan A.;Wang A.-Y.; Wang A.-Y.; Yuan A.; Huang C.-H. |
| 臺大學術典藏 |
2012 |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Wang A.-Y.; Yuan A.; Huang C.-H.; Chang W.-T.; Liang P.-C.; TZU-HSIN LIN; Chen S.-C. |
| 臺大學術典藏 |
2020-12-07T07:11:48Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Wang A.-Y.; Yuan A.; Huang C.-H.; Chang W.-T.; Liang P.-C.; Lin T.-H.; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2020-12-16T07:56:45Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Wang A.-Y.; Yuan A.; Huang C.-H.; Chang W.-T.; Liang P.-C.; Lin T.-H.; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2020-12-24T07:08:25Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Wang A.-Y.; Yuan A.; Huang C.-H.; WEI-TIEN CHANG; Liang P.-C.; Lin T.-H.; Chen S.-C. |
| 臺大學術典藏 |
2020-12-16T07:42:34Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
CHIEN-HUA HUANG; Chang W.-T.; Liang P.-C.; Lin T.-H.; Chen S.-C.; Wang A.-Y.;Yuan A.;Chien-Hua Huang;Chang W.-T.;Liang P.-C.;Lin T.-H.;Chen S.-C.; Wang A.-Y.; Yuan A. |
| 中國醫藥大學 |
2005-05-11 |
Recombinant factor VIIa used as an adjunctive method of hemostasis management in pelvic fracture patients after massive transfusion and transcatheter arterial embolization.
|
陳瑞杰 |
| 中國醫藥大學 |
2005-05 |
Recombinant factor VIIa used as an adjunctive method of hemostasis management in pelvic fracture patients after massive transfusion and transcatheter arterial embolization.
|
陳瑞杰(Ray-Jade Chen); 鍾斌魁(Ping-Kuei Chung); 王毓駿(Yu-Chun Wang); 楊宏仁(Horng-Ren Yang); 謝奇勳(Chi-Hsun Hsieh); 鄭隆賓(Long-Ben Jeng) |
| 國立臺灣科技大學 |
2018 |
Recombinant fructosyl peptide oxidase preparation and its immobilization on polydopamine coating for colorimetric determination of HbA1c
|
Chen K.-J.; Wang C.-H.; Liao C.-W.; Lee C.-K. |
| 國家衛生研究院 |
2012-10 |
Recombinant heat shock protein 70 in combination with radiotherapy as a source of tumor antigens to improve dendritic cell immunotherapy
|
Wang, YS;Liu, SJ;Huang, SC;Chang, CC;Huang, YC;Fong, WL;Chi, MS;Chi, KH |
| 國家衛生研究院 |
2019-04 |
Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development
|
Chen, TH;Liu, WC;Chen, IC;Liu, CC;Huang, MH;Jan, JT;Wu, SC |
| 國家衛生研究院 |
2017-09-22 |
Recombinant hemagglutinin proteins formulated in a novel PELC/CpG adjuvant for H7N9 subunit vaccine development
|
Chen, TH;Liu, YY;Jan, JT;Huang, MH;Spearman, M;Butler, M;Wu, SC |
| 國立臺灣大學 |
2007 |
Recombinant Human Acid Alpha-Glucosidase - Major Clinical Benefits in Infantile-Onset Pompe Disease
|
胡務亮; 簡穎秀; 陳垣崇; HWU, WUH-LIANG; CHIEN, YIN-HSIU; CHEN, YUAN-TSONG |
| 臺大學術典藏 |
2020-12-16T02:26:03Z |
Recombinant human acid α-glucosidase: Major clinical benefits in infantile-onset Pompe disease
|
Kishnani P.S.;Corzo D.;Nicolino M.;Byrne B.;Mandel H.;Wuh-Liang Hwu;Leslie N.;Levine J.;Spencer C.;Mcdonald M.;Li J.;Dumontier J.;Halberthal M.;Chien Y.H.;Hopkin R.;Vijayaraghavan S.;Gruskin D.;Bartholomew D.;Van Der Ploeg A.;Clancy J.P.;Parini R.;Morin G.;Beck M.;De La Gastine G.S.;Jokic M.;Thurberg B.;Richards S.;Bali D.;Davison M.;Worden M.A.;Chen Y.T.;Wraith J.E.; Kishnani P.S.; Corzo D.; Nicolino M.; Byrne B.; Mandel H.; WUH-LIANG HWU; Leslie N.; Levine J.; Spencer C.; McDonald M.; Li J.; Dumontier J.; Halberthal M.; Chien Y.H.; Hopkin R.; Vijayaraghavan S.; Gruskin D.; Bartholomew D.; Van Der Ploeg A.; Clancy J.P.; Parini R.; Morin G.; Beck M.; De La Gastine G.S.; Jokic M.; Thurberg B.; Richards S.; Bali D.; Davison M.; Worden M.A.; Chen Y.T.; Wraith J.E. |
| 臺大學術典藏 |
2020-12-24T06:17:11Z |
Recombinant human acid α-glucosidase: Major clinical benefits in infantile-onset Pompe disease
|
Wraith J.E.; Chen Y.T.; Worden M.A.; Davison M.; Kishnani P.S.; Corzo D.; Nicolino M.; Byrne B.; Mandel H.; Hwu W.L.; Leslie N.; Levine J.; Spencer C.; McDonald M.; Li J.; Dumontier J.; Halberthal M.; YIN-HSIU CHIEN; Hopkin R.; Vijayaraghavan S.; Gruskin D.; Bartholomew D.; Van Der Ploeg A.; Clancy J.P.; Parini R.; Morin G.; Beck M.; De La Gastine G.S.; Jokic M.; Thurberg B.; Richards S.; Bali D. |
| 中國醫藥大學 |
2010 |
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated activation of Src and inactivation of PTEN
|
(Liang K,); (Esteva FJ); (Albarracin C); (Stemke-Hale K); (Lu Y); (Bianchini G); (Yang CY); (Li Y,); (Li X); (Chen CT); (Mills GB); (Hortobagyi GN); (Mendelsohn J); 洪明奇(Mien-Chie Hung); (Fan Z.)* |
